Upperton Pharma Solutions, a leading Nottingham-based pharmaceutical contract development and manufacturing organisation (CDMO), is proud to announce its recognition as one of The Sunday Times Best Places to Work 2025. This prestigious accolade celebrates organisations across the UK that excel in employee experience and workplace culture.
The Sunday Times Best Places to Work Awards, powered by WorkL, evaluate organisations based on comprehensive employee surveys. These surveys assess key engagement drivers, including Reward & Recognition, Information Sharing, Empowerment, Pride, Job Satisfaction, and Wellbeing. To qualify, companies must achieve a minimum overall engagement score of 70%. Being named in the list signals that an organisation not only meets these benchmarks but also demonstrates a consistent commitment to building a workplace culture that enables people to perform and grow.
Nikki Whitfield, CEO of Upperton Pharma Solutions, expressed her pride in the achievement:
“Being recognised as one of The Sunday Times Best Places to Work is a testament to our commitment to our employees. We invest in creating a working culture that supports both technical excellence and professional growth, and it’s encouraging to see those efforts reflected in this result”.
Upperton’s inclusion in the 2025 list follows a year of significant milestones, including expansion into sterile manufacturing and investment in talent across scientific and operational teams. The company’s culture, emphasising collaboration, innovation, and employee empowerment, has been instrumental in driving its growth and success.
Nicola Beer, HR Manager at Upperton, added:
“This recognition underscores our focus on fostering a culture where every employee feels valued and heard. We continuously strive to implement initiatives that promote wellbeing, professional growth, and innovation within our organisation.”
Upperton Pharma Solutions specialises in formulation development, clinical trial manufacturing, and commercial manufacturing across various dosage forms, including oral solids, liquids, semi-solids, inhalation and sterile products. With a state-of-the-art 60,000 sq ft facility in Nottingham, the company offers integrated CDMO services from pre-clinical development through to market supply.
Article written by Upperton, contact:
Rob Halliwell, Associate Director of Marketing, Upperton
[email protected]
